SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005554
Filing Date
2020-05-07
Accepted
2020-05-07 08:06:48
Documents
45
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q albo-20200331x10q.htm 10-Q 1060085
2 EX-10.1 albo-20200331ex101b6e873.htm EX-10.1 31488
3 EX-10.2 albo-20200331ex1028308fc.htm EX-10.2 111064
4 EX-31.1 albo-20200331ex311cd3ae8.htm EX-31.1 11735
5 EX-31.2 albo-20200331ex3126703aa.htm EX-31.2 12419
6 EX-32.1 albo-20200331ex32158a2ce.htm EX-32.1 12220
7 GRAPHIC albo20200331ex1028308fc001.jpg GRAPHIC 144073
  Complete submission text file 0001558370-20-005554.txt   2888715

Data Files

Seq Description Document Type Size
8 EX-101.INS albo-20200331.xml EX-101.INS 308435
9 EX-101.SCH albo-20200331.xsd EX-101.SCH 21161
10 EX-101.CAL albo-20200331_cal.xml EX-101.CAL 26559
11 EX-101.DEF albo-20200331_def.xml EX-101.DEF 36347
12 EX-101.LAB albo-20200331_lab.xml EX-101.LAB 185384
13 EX-101.PRE albo-20200331_pre.xml EX-101.PRE 122134
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 20854661
SIC: 2834 Pharmaceutical Preparations